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I M M UNOLOGY
Aging-associated deficit in CCR7 is linked to worsened 
glymphatic function, cognit ion, neuroinflammation, 
and amyloid pathology
Sandro Da Mesquita1*†‡, Jasmin Herz2,3†, Morgan Wall1, Taitea Dykstra2,3, Kalil Alves de Lima2,3, 
Geoffrey T. Norris4, Nisha Dabhi1, Tat iana Kennedy1, Wendy Baker1, Jonathan Kipnis1,2,3*
Aging leads to a progressive deterioration of meningeal lymphatics and peripheral immunity, which may acceler-
ate cognit ive decline. We hypothesized that an age-related reduction in C-C chemokine receptor type 7 (CCR7)–
dependent egress of immune cells through the lymphatic vasculature mediates some aspects of brain aging and 
potentially exacerbates cognitive decline and Alzheimer’s disease–like brain amyloid (A ) pathology. We report 
a reduction in CCR7 expression by meningeal T cells in old mice that is linked to increased effector and regulatory 
T cells. Hematopoietic CCR7 deficiency mimicked the aging-associated changes in meningeal T cells and led to 
reduced glymphatic influx and cognitive impairment. Deletion of CCR7 in 5xFAD transgenic mice resulted in del-
eterious neurovascular and microglial activation, along with increased A  deposition in the brain. Treating old 
mice with anti-CD25 antibodies alleviated the exacerbated meningeal regulatory T cell response and improved 
cognitive function, highlighting the therapeutic potential of modulating meningeal immunity to fine-tune brain 
function in aging and in neurodegenerative diseases.
INTRODUCTION
Aging-related neurological disorders are rapidly becoming a major 
financial burden on health care worldwide. Alzheimer’s disease 
(AD) is the most prevalent aging-associated dementia, accounting 
for 60 to 80% of all dementia cases and affecting close to half of the 
elderly population over the age of 85 (1, ). AD is characterized by 
severe behavioral deficits, particularly in cognitive faculties, whose 
underlying pathophysiological mechanisms are poorly understood 
and lack effective treatments (3–5). Accumulating evidence over the 
past decade has shown a close association between changes in 
neuroimmune-related mechanisms and the etiology and progression 
of AD (6–11). Microglia, the brain-resident immune cells, have been 
extensively studied and seem to play a central role in modulating 
AD pathology (11–15). Less attention has been focused, however, 
on changes in the adaptive immune response at the brain-meningeal 
border in aging and in AD.
The meninges, which ensheath the brain, comprise a unique 
neuroimmune interface, harboring a diverse immune cell popula-
tion that plays an essential role in maintaining brain homeostasis 
(16–18) and in fine-tuning processes such as neuroinflammation, 
tissue repair, and neuronal activity (19–25). Notably, different be-
havioral aspects such as cognition, sociability, and anxiety are mod-
ulated by meningeal T cell–derived cytokines that signal directly to 
their cognate receptors expressed on neurons (19, , 5). The brain 
meninges also harbor bona fide lymphatic vessels that constantly 
drain molecular solutes from the cerebrospinal fluid (CSF) into the 
cervical lymph nodes (23, 6, 7). Aging in mice was recently shown 
to induce a deleterious loss of meningeal lymphatic coverage and 
drainage capacity, which is closely associated with cognitive decline 
(28). Ablation of the meningeal lymphatic vasculature in adult mice 
resulted in deficient clearance of brain solutes through the glym-
phatic system, as well as cognitive impairment and accumulation of 
amyloid (A ) in the brains of familial AD transgenic mice (28). 
Besides draining CSF, the lymphatic vasculature also regulates the 
immune response in the brain meninges (17, 3). Notably, it was 
shown that meningeal immune cell egress is mediated by C-C chemo-
kine receptor type 7 (CCR7) expression and that ablation of meningeal 
lymphatic vessels in a model of neuroinflammation results in altered 
activation of T cells in the cervical lymph nodes (23).
Aging induces marked changes in the immune system (18, 9, 30). 
Moreover, the role of adaptive immune cells in AD was emphasized 
by reports showing altered AD-related A  brain pathology in immuno-
deficient mouse models (31, 32). Little is known, however, about 
the effects of aging on meningeal immunity and whether changes in 
meningeal immunity underlie the observed deficient clearance of 
brain waste and the build-up of A  n AD (17, 8, 33, 34). Here, in 
exploring the meningeal immune profiles of old mice, we observed 
a reduction in CCR7 expression by T cells. To investigate a potential 
link between this decreased CCR7 expression in immune cells and 
brain dysfunction, we examined the changes in meningeal immunity, 
cognition, glymphatic function, and brain single-cell transcriptomic 
profile in CCR7-deficient mice. We also provide evidence showing 
that decreased CCR7 expression affects brain A  pathology and 
cognitive function in a mouse model of familial AD and that nor-
malization of the exacerbated regulatory T cells (Tregs) in the aged 
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analysis of the T cell response in mouse meningeal preparations 
(composed mostly of dural and arachnoid layers) revealed a sig-
nificantly larger number of T cells (NK1.1−TCR ) in old mice 
(24 to 25 months of age) than in adult (2 to 3-month-old) mice 
(Fig. , to C), confirming previously published findings (14). 
Assessment of forkhead box P3 (FOXP3) expression by meningeal 
leukocytes revealed a significant increase in the frequency and num-
ber of CD4+FOXP3+ Tregs in the old mice (Fig. D and fig. S1A). 
Assessment of the brain-draining deep cervical lymph nodes (dCLNs) 
revealed decreased frequency of T cells and an increase in frequency 
of the Tregs in old mice (Fig. , to ). Together, this translated 
into an overall significant decrease in the number of CD4+FOXP3− 
effector T cells (fig. S1B). Analysis of blood and liver samples re-
vealed no differences in total CD45+ cells or in CD4+FOXP3+ Tregs 
between adult and old mice (fig. S1, C to J).
We have previously shown that impaired signaling through 
CCR7 results in accumulation of T cells in the brain meninges (23). 
To find out whether altered CCR7 expression could explain the 
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Fig. 1. Aging leads to abnormal Treg response and reduced CCR7
+ T cell frequency in the brain meninges and draining lymph nodes. (A) Representative flow cy-
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increase in T cell numbers observed in the meninges of old mice, we 
performed direct ex v vo staining of CCR7 (fig. S1K) on meningeal 
immune cells from mice at the ages of 4 months (adult) and 25 months 
(old). A smaller proportion of CCR7-expressing T cells, including 
CD4+FOXP3+CCR7+ Tregs, was observed in meninges of the old 
mice than of the adult mice (Fig. , to , and fig. S1, L to O). De-
creased proportions of CCR7-expressing effector T cells and Tregs 
were also observed in the dCLNs of old mice (Fig. , N to , and fig. 
S1, P to S). These data indicate that old mice exhibit T cell accumu-
lation in the meninges and decreased T cell retention in the dCLNs, 
possibly owing to their lack of CCR7 and their impaired migration 
capacity.
Next, we used CCR7GFP reporter mice to evaluate CCR7 ex-
pression levels in adult (3-month-old) and middle-aged (12- to 
14-month-old) mice. Analysis of the brain cortex, choroid plexus, 
and meninges of adult CCR7GFP reporter mice by flow cytometry 
(fig. S2, A to C) showed that most of the brain-associated CCR7high 
leukocytes are predominantly found in the meninges (fig. S2B). 
Moreover, a significantly higher frequency of CCR7high leukocytes 
was observed in the dCLNs than in the blood and liver (fig. S2C), 
again underscoring the importance of CCR7 as a mediator of leuko-
cyte egress through lymphatic vessels from the meninges into the 
dCLNs. We also found that most of the CCR7high leukocytes in the 
meninges were also T cell receptor positive (TCR ; ~83% of to-
tal CD45+CCR7high; fig. S2, D and E) and that ~27% of meningeal 
CD4+CD25+ T cells expressed high levels of CCR7 (fig. S2F). Ap-
proximately 96% of CCR7high leukocytes in the dCLNs and 95% in 
the blood were TCR  (fig. S2, D and E), and more than half of the 
CD4+CD25+ T cells in the dCLNs expressed high levels of CCR7 
(fig. S2F). Thus, consistent with our ex v vo staining data, the 
middle-aged CCR7GFP reporter mice showed a significant decrease 
in CCR7-expressing TCR  T cells, relative to their adult counter-
parts in the meninges and dCLNs (fig. S2, G and H), but not in the 
blood or liver (fig. S2, I and J).
Together, these results point to a heightened Treg response in the 
brain meninges and draining dCLNs of old mice, with concomitant 
reduction in CCR7high T cells. In line with our data, previous studies 
have reported an increased frequency of CD4+FOXP3+ Tregs in the 
spleen and peripheral lymph nodes of old mice relative to their 
younger counterparts (35).
CCR7 deficiency boosts meningeal Tregs in adult mice
To find out whether a decrease in CCR7 expression in the hemato-
poietic compartment would mimic the observed aging-related effects 
on meningeal immunity, we irradiated adult wild-type (WT) mice 
(while covering their heads with a lead shield to preserve brain-res-
ident immune cells) and then carried out adoptive transfer of bone 
marrow cells isolated from WT or CCR7-deficient (CCR7−/−) do-
nor mice (see fig. S3A for more experimental details). As observed 
earlier in old mice, mice that received CCR7−/− bone marrow also 
showed increased numbers of CD4+ (and CD8+) T cells in the 
enabled us to identify 21 clusters (and a cluster of undefined cells; 
Fig. G and fig. S4A), of which only cells of the CD4 and CD8 clus-
ters were significantly increased in CCR7−/− mice (Fig. H). This 
increased number of meningeal T cells in the CCR7−/− group was 
associated with a decrease in the number of cells in the macrophage 
2 cluster (Fig. H). Upon closer analysis of activation markers and 
transcription factor expression on cells from the three identified 
CD3+TCR  T cell clusters (CD4, CD8, and double-negative T cells; 
fig. S4B), we observed an increased frequency of CD8+T-betlow 
T cells and of CD4+FOXP3+ Tregs in the meninges of CCR7
−/− mice 
(Fig. , and J). The increased frequency of meningeal Tregs in the 
CCR7−/− group was accompanied by a decrease in all T-bethigh T cell 
subclusters (Fig. , and J). Flow cytometric analysis of ex v vo–
stimulated meningeal T cells confirmed the increase in frequency of 
CD4+FOXP3+ Tregs in CCR7
−/− mice and a concomitant decrease in 
frequency of interferon-  (IFN- )–producing CD4 T cells (fig. S4, 
C to F). Both CD4 and CD8 meningeal T cells from the CCR7−/− 
group showed a trend toward decreased IFN-  production relative 
to the WT control (fig. S4, G to I). The increase in Tregs in the 
CCR7−/− group was evident in the meninges and dCLNs but was 
only minor in the liver and was not detected in the blood (fig. S5). 
Together, these results show that CCR7 deficiency (either constitu-
tive or upon BMT) leads to an aging-like dysregulated T cell re-
sponse, characterized by decreased T-bethigh and IFN- producing 
CD4 T cells and an abnormal increase in Tregs in the brain meninges 
and dCLNs.
Hematopoiet ic CCR7 deficiency hinders spatial memory 
and glymphatic funct ion
T cells participate in the modulation of neuronal activity and higher 
cognitive functions (19, 2, 5, 36). In view of the abnormal T cell 
response due to CCR7 deficiency, we compared the performance of 
5- to 7-month-old CCR7−/− mice and their age-matched WT litter-
mates in different behavioral tests. In the open-field test, both groups 
showed comparable values in terms of total distance traveled, velocity, 
and time spent in the center of the arena, which indicated similar 
exploratory activity and anxiety-like behavior (fig. S6, A to C). 
Equivalent performances in the open field were also observed after 
(WT or CCR7−/−) BMT (fig. S6, D to F). However, both CCR7−/− 
mice (Fig. 3, to ) and WT mice that had received CCR7−/− bone 
marrow (at 4 months of age; Fig. 3, to J) performed worse in the 
novel location recognition and Morris water maze (MWM) tests 
than their respective controls. These results are in line with previ-
ously reported learning deficits displayed by CCR7−/− mice in the 
Barnes maze test (37), reinforcing the notion that impaired CCR7- 
dependent immune cell egress is associated with worse cogni-
tive function.
Reduced meningeal lymphatic drainage has been linked to both 
aging-related cognitive decline and impaired recirculation of CSF 
through the brain via the glymphatic system (28). On the basis of 
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Fig. 2. CCR7 deficiency in hematopoiet ic cells mimics the aging-related dysregulated meningeal T cell response. (A to F) Bone marrow (BM) from 2-month-old WT 
or CCR7-deficient (CCR7−/−) mice was transferred into irradiated (head-covered) WT recipients (6 weeks old). Immune response and behavior were assessed 10 weeks 
later. Quantification of CD45+ZA− cell number, representative flow cytometry dot plots, and quantification of DN, CD4+, and CD8+ T cell numbers in the (A to C) meninges 
and (D to F) dCLNs. Data are presented as means ± SEM; n = 5 per group; two-tailed unpaired Student’s t test in (A) and (D); two-way ANOVA with Sidak’s multiple compar-
isons test in (C) and (F). (G) t-distributed stochastic neighbor embedding–based visualization (viSNE) plots showing unsupervised clustering profile of subpopulations of 
CD45+ live immune cells. NK cells, natural killer cells; RBCs, red blood cells. (H) Volcano plot with change in frequency (in percentage) of subpopulations of meningeal 
leukocytes in CCR7−/− mice (relative to WT, n = 5 per group). Individual data points represent the mean for each leukocyte population; multiple two-tailed unpaired 
Student’s t tests with two-stage step-up method of Benjamini, Krieger, and Yekutieli and false discovery rate (FDR) (Q) = 0.05. (I) viSNE plots showing clustering of sub-
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